Instil Bio, Inc.

NasdaqCM:TIL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 177.18 M

Share Price

USD 27.01

Avg Daily Volume

312,817

Change (1 day)

-4.46%

Change (1 year)

118.70%

Change (YTD)

41.49%

Instil Bio, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -879.37%

Instil Bio, Inc. EBIT Margin is -879.37% for the Trailing 12 Months (TTM) ending September 30, 2024. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Competitors

CytomX Therapeutics, Inc.

USD 2.32

CTMX

+0.07 3.11%

Assembly Biosciences, Inc.

USD 17.90

ASMB

-0.46 -2.50%

Edgewise Therapeutics, Inc.

USD 14.23

EWTX

+0.28 2.01%

Nuvation Bio Inc.

USD 2.41

NUVB

-0.05 -2.03%

Design Therapeutics, Inc.

USD 4.03

DSGN

+0.05 1.26%

Lyell Immunopharma, Inc.

USD 12.44

LYEL

-0.43 -3.34%

View all

Key Data

Date	EBIT Margin	EBITDA Margin	Net Income Margin	EBT Margin